| Statistics on completed consultations awaiting update 5 March 2025 | ||||||||||
 |
||||||||||
|
A : PCT Completed consultation Fedlex - B : Standby PCT - C : PCT classified from last year |
||||||||||
|
Status of planned consultations (CForeseen ), in progress (CeC) and Completed (PCT ) awaiting conclusion |
Year | 2022 | 2023 | 2024 | 2025 | |||||
| CForeseen | 89 | 88, 95 | 19, 39, 44, 65, 78, 79, 82,86, 95, 92, 93, 94,97, 98, 99, 101, 103, 104, | 4, 7, 9, 10, 11, 12, 13, 14, 15, | ||||||
| CeC | 21 | 91, 104 | 24, 26, 36, 49, 66, 67, 74, 75, 76, 77, 80, 83, 88, 89, 90, 91, 96, 100, 102 | |||||||
| Number of analysis per year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Totals - % |
| PCT Fedlex | 70 | 95 | 91 | 86 | 73 | 91 | 90 | 103 | 85 | 784 |
| Standby PCT | 3 | 21 | 28 | 42 | 40 | 50 | 85 | 87 | 54 | 410 - 52 % |
| PCT classified from last year | 0 | 0 | 2 | 3 | 7 | 10 | 4 | 11 | 3 | 40 - 5 % |
| Total leg-em laws | 3 | 46 | 58 | 67 | 98 | 65 | 87 | 124 | 85 | 633 |
| PCT P/Acts | 0 | 2/3 | 2/3 | 1/4 | 4/4 | 2/4 | 1/1 | 3/20 | 3/10 | 18/49 |
|
List of PCT awaiting update in laws
Legend : R: Awaiting the Results Report P: Partial update |
17, 37, 47 | 4, 7, 14, 29, 36, 37/4, 45/6, 47/5, 51, 52, 55, 58, 67, 70/2, 83, 84, 87-P2/7, 90/4, 91-1/4, 93, 95 | 3, 7, 10/2, 13, 16, 18/5, 19, 20, 22, 23, 24, 26, 29, 32, 35, 38/5, 44/12, 47, 48-P2/4, 50, 56, 70, 72, 74/6, 79/2, 80-P1/2, 89, 92 | 1, 3, 9, 12, 13, 14, 16, 19/2, 20, 21/3, 22, 23/3, 24, 26/2, 27, 30, 36/2, 38, 39, 43, 44/2, 47, 50-P1/4, 51, 53, 55/5, 57, 60, 63, 65/2, 68, 71/4, 72,74, 75/2, 76, 77/4, 82, 83/2, 85/2, 87/2, 88 | 1, 4-P1/9, 5, 6/2, 10/5, 15, 16-C1/3, 18/2, 19, 45, 20, 22, 27, 29, 30, 32, 35/2, 36, 37, 40, 43/7, 45, 46/2, 47, 48/2, 50/44, 51, 53-P1/9, 54/2, 55-P1/2, 56, 57/7, 60-63, 64, 67/14, 70/3, 71/8, 72, 73,74/3 | 7, 8, 11/2, 12, 17, 18, 20, 28, 29, 30/2, 32, 33, 37, 38, 39/2, 40-P1/2, 43, 44, 50, 51, 53-P1/3, 59, 63, 64, 69, 76, 77/2, 79, 80-82, 83/2, 84, 85, 90, 91, 93, 94, 95/2, 97, 105/2, 107, 108/3, 109, 111, 114, 117, 121, 122, 124-P3/4 | 1, 2+, 3, 4+, 5+, 6, 7, 8, 9+/2, 12, 14+, 15+, 16, 17 - 20, 22, 23, 24+, 25, 26, 27, 28+, 29_, 31+, 32, 33, 34+, 36+, 37, 38+, 39+, 40, 41+, 42, 44+, 45, 46, 47+, 48+ , 50 - 63, 64+, 65, 66, 67, 68+C1/2, 69, 71, 72, 73, 74+, 75, 77 - 82, 84 - 88, 90+, 91+ , 93, 94 , 96 , 97, 98 , 102+ | 1, 3-5, 6-P2/4, 7, 9-17, 19, 23-25, 26-P1/5, 27-39, 41-44, 47, 49/3, 50, 52, 53, 55, 56, 57-P15/23, 58-60, 63-83, 85-87, 90, 92 ,94, 96-101, 102-1/6, 103 ,105-109-1/2 | 1, 2-P4/26, 3-18, 20, 21-P1/2, 22, 23, 25, 28-P1/4, 29-31, 33, 37, 40, 42, 45/3, 46-48, 50, 53-64, 68 , 70, 73 | |
| PCT classified from last year | 0 | 0 | 9, 88 | 32, 33, 49 | 17-3/3, 23-2/2, 28, 33, 52, 53, 55 | 2-2/2, 4-2/2, 31, 36, 88, 96, 100, 102, 118, 126 | 10_, 11, 35_, 49_4/4 | 2, 8, 10, 22, 23, 24, 40, 45, 46, 51, 54 | 21, 27, 35/2 | |
| 3 March 2025 - Responsible: Daniel Glanzmann, Glanzware SA | ||||||||||